Portfolio Co Investors 2026 for Sherpa Healthcare Partners: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Sherpa Healthcare Partners accounts for 18 tracked companies with verified cap-table data, 18 of which disclose round sizes totalling $2.1B. The median disclosed raise is $90M, and the largest is Hong Kong Asia Heart Centre at $400M, ahead of EpimAb Biotherapeutics ($219M) and ClinChoiceKunling ($212M).
The names that recur most often on these co-invested cap tables are Sherpa Healthcare Partners (18 companies), Lilly Asia Ventures (7 companies), Legend Capital (4 companies), IDG Capital (3 companies), Cormorant Asset Management (2 companies), Hony Capital (2 companies). By latest disclosed round, the market skews Series B (6), Series A (6), Series D (2), Series E (2).
Companies tracked: 18
Disclosed funding total: $2.1B across 18 companies
Median disclosed raise: $90M
Largest raise: Hong Kong Asia Heart Centre — $400M
Stage mix: Series B 6 · Series A 6 · Series D 2 · Series E 2
